Thrasos Therapeutics Appoints Dr. Andreas Orfanos as Chief Medical Officer
9/20/2011 10:10:52 AM
MONTREAL--(BUSINESS WIRE)--Thrasos, Inc. today announced the appointment of Dr. Andreas Orfanos, MBBCh, FFPM, as Chief Medical Officer. Dr. Orfanos has over 25 years of international experience in strategy development and executive and operational management in major healthcare sectors, with a particular focus on global pharmaceuticals and biotechnology.
comments powered by